Marker Therapeutics, Inc. (MRKR)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Mar 13, 16:00
1.34
+0.01
(+0.75%)
After-Hours: 20:00
Marker Therapeutics Total Liabilities (Quarterly) : 3.346M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 177.25M |
| ADMA Biologics, Inc. | 156.03M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Kiniksa Pharmaceuticals International Plc | 196.03M |
| Neurocrine Biosciences, Inc. | 1.500B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.73M |
| Shareholders Equity (Quarterly) | 18.39M |
| Current Ratio | 6.496 |